| scholarly article | Q13442814 |
| P50 | author | Patrizia Rovere-Querini | Q62579985 |
| P2093 | author name string | Norma Maugeri | |
| Angelo A Manfredi | |||
| Maria Grazia Sabbadini | |||
| Stefano Franchini | |||
| Giuseppe A Ramirez | |||
| P2860 | cites work | Platelet, not endothelial, P-selectin expression contributes to generation of immunity in cutaneous contact hypersensitivity | Q39403266 |
| Serotonin induced platelet aggregation in systemic sclerosis | Q41431389 | ||
| Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine | Q43740421 | ||
| Coagulative modifications in patients with systemic sclerosis treated with iloprost or nifedipine. | Q43788021 | ||
| Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells | Q44179199 | ||
| Raynaud's phenomenon and serotonin reuptake inhibitors | Q45093403 | ||
| Supranormal von Willebrand factor multimers in scleroderma | Q45884878 | ||
| The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis. | Q45956278 | ||
| Platelet activation in patients with systemic scleroderma--pattern and significance. | Q46708316 | ||
| The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling | Q47245105 | ||
| Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls | Q49051672 | ||
| Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. | Q52118613 | ||
| Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis. | Q52872695 | ||
| Platelet sensitivity to a prostacyclin analogue in systemic sclerosis. | Q53690099 | ||
| A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3 | Q58657596 | ||
| P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues | Q58808007 | ||
| Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts | Q60537787 | ||
| Increased platelet sensitivity to collagen-induced aggregation in whole blood patients with systemic sclerosis | Q67951191 | ||
| Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon | Q68450924 | ||
| Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis | Q69425734 | ||
| Localization of platelet antigens in human kidney disease | Q70149169 | ||
| Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma | Q72664368 | ||
| Mechanism of serum-mediated endothelial injury in scleroderma: identification of a granular enzyme in scleroderma skin and sera | Q73162633 | ||
| Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma | Q73167884 | ||
| Relative roles of endothelial cell damage and platelet activation in primary Raynaud's phenomenon (RP) and RP secondary to systemic sclerosis | Q77305761 | ||
| Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension | Q77822568 | ||
| Defective vasculogenesis in systemic sclerosis | Q80457437 | ||
| Scleroderma fibroblasts constitutively express the long pentraxin PTX3 | Q80519862 | ||
| Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis | Q82087275 | ||
| Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity | Q82117666 | ||
| Carcinoid heart disease | Q83399533 | ||
| Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 | Q84309344 | ||
| Platelets mediate cytotoxic T lymphocyte-induced liver damage | Q24604707 | ||
| Platelets, inflammation and tissue regeneration | Q28235158 | ||
| Evolution of the pentraxin family: the new entry PTX4 | Q28278392 | ||
| Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood | Q28294906 | ||
| A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients | Q30478833 | ||
| Interstitial lung disease (ILD) and severe ITP. | Q33374583 | ||
| Platelet serotonin in systemic sclerosis | Q33561867 | ||
| Platelets in defense against bacterial pathogens | Q33604443 | ||
| Innate immunity and inflammation in systemic sclerosis | Q33767356 | ||
| Autoimmunity and vascular involvement in systemic sclerosis (SSc). | Q33876515 | ||
| An integrated view of humoral innate immunity: pentraxins as a paradigm | Q34020449 | ||
| Platelet-mediated lymphocyte delivery to high endothelial venules | Q34384171 | ||
| Platelet-derived serotonin links vascular disease and tissue fibrosis | Q34973681 | ||
| Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis | Q35555294 | ||
| Vascular involvement in systemic sclerosis (scleroderma). | Q35557424 | ||
| Changes in causes of death in systemic sclerosis, 1972-2002 | Q35954516 | ||
| Atherosclerosis as inflammation | Q36043582 | ||
| In vivo platelet production from mature megakaryocytes: does platelet release occur via proplatelets? | Q36090943 | ||
| Transforming growth factor-beta: a key mediator of fibrosis | Q36239091 | ||
| Systemic and cell type-specific gene expression patterns in scleroderma skin | Q36349808 | ||
| Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin-deficient mice. | Q36400175 | ||
| Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study. | Q36450708 | ||
| Type I interferon in systemic lupus erythematosus and other autoimmune diseases | Q36595839 | ||
| Platelet contributions to the pathogenesis of systemic sclerosis | Q36961456 | ||
| Pentraxins, humoral innate immunity and tissue injury | Q37200012 | ||
| Role of PDGF in fibrotic diseases and systemic sclerosis | Q37265804 | ||
| Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis. | Q37421806 | ||
| Dangerous connections: neutrophils and the phagocytic clearance of activated platelets | Q37601206 | ||
| Platelets and the immune continuum | Q37857647 | ||
| Contemporary management of Raynaud's phenomenon and digital ischaemic complications | Q37925438 | ||
| Platelet-leukocyte deregulated interactions foster sterile inflammation and tissue damage in immune-mediated vessel diseases. | Q37975846 | ||
| HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease | Q37980335 | ||
| P304 | page(s) | 160 | |
| P577 | publication date | 2012-06-18 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | The role of platelets in the pathogenesis of systemic sclerosis | |
| P478 | volume | 3 |
| Q100559306 | Dermal fibroblasts have different extracellular matrix profiles induced by TGF-β, PDGF and IL-6 in a model for skin fibrosis |
| Q93152908 | Emerging Factors Implicated in Fibrotic Organ-Associated Thrombosis: The Case of Two Organs |
| Q49630769 | From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis |
| Q52680357 | From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders. |
| Q38427670 | Parietal and intravascular innate mechanisms of vascular inflammation |
| Q38763707 | Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications |
| Q38101678 | Platelets and autoimmunity. |
| Q92106724 | Platelets in Skin Autoimmune Diseases |
| Q41452150 | Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease |
| Q64277722 | The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis |
| Q26749091 | Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis |
Search more.